Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis.
Author(s) -
Robert N. Willette,
Charles F. Sauermelch,
R Rycyna,
Sandip Sarkar,
G Feuerstein,
Andrew J. Nichols,
Eliot H. Ohlstein
Publication year - 1992
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.23.5.703
Subject(s) - medicine , thrombosis , cardiology , aspirin , platelet , common carotid artery , anesthesia , ex vivo , thrombus , in vivo , carotid arteries , microbiology and biotechnology , biology
Platelet-fibrin thrombi in the lumen of atherostenotic carotid arteries may underlie transient ischemic attacks and cerebral infarction. For this reason, we investigated the antiplatelet and antithrombotic effects of a novel and potent platelet fibrinogen receptor (glycoprotein IIb/IIIa) antagonist (SK&F 106760).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom